Bob has over 40 years of experience in the high technology industry, and is currently managing director at Gutbrain Ventures. Gutbrain Ventures is an independent venture firm that invests primarily in technology enterprise software companies. The firm’s first fund (Gutbrain I), which is now closed, had $100mm AUM and 57 portfolio companies. Gutbrain II, the second iteration fund, is currently open, and has another $100mm AUM and 8 active investments. The average deal size ranges between $1-5mm but have been as small as $500k and a large as $18mm for a single deal. Bob believes the success of a startup lies in the people and technology and looks for passionate founders to back his portfolio companies.
Bob joined Sigma Partners in 1995. His ability to identify and motivate innovative founding teams has been an essential ingredient of his investment success. Bob regularly leverages his deep operational experience and technology intellect to support the firm’s portfolio companies.
Prior to joining Sigma Partners, Bob was President & CEO of Epoch Systems, the leading vendor of client-server data management software products. He sold the firm in 1993 to EMC for $141 million. Previously, he was the Founder, President and CEO of SQL Solutions, a leading purveyor of services and tools for the relational database market. Bob sold SQL Solutions to Sybase for stock eventually worth over $100 million. Bob served as an executive officer of Sybase for over two years.
In recent years, Bob has appeared five times on the Forbes’ Midas list, a ranking of top venture capitalists. He also appeared on the cover of Business Week in a features story describing how VCs thrive through good and tough times. He is also an avid singer-songwriter. www.bobdavoli.com
Bill joined Greylock in 1984. He is focused on just about any company or idea which is unique and interesting and has a chance to be important and which is backed by a dedicated and passionate management team. Bill represents Greylock on the boards of Music Nation , Reveal Imaging , and Zipcar . Bill also led Greylock's investments in Exact Sciences , Upromise (merged with Sallie Mae), Outlooksoft (merged with SAP), Tessera (merged with iXL), Ontogeny (merged with Curis), Hyperion Software (merged with Oracle), Filene's Basement , Pharmacopeia , Millennium Pharmaceuticals , Staples.com (merged with Staples), Mitotix (merged with GPC Biotech) and Vertex Pharmaceuticals . In addition, Bill serves on the Boards of Harvard Management Company, the Isabella Stuart Gardner Museum, and The Steppingstone Foundation. He is also a member of the board of overseers at the Museum of Fine Arts and chair of the President&rsquo